MY125870A
(en)
*
|
1997-07-25 |
2006-08-30 |
Alza Corp |
Osmotic delivery system flow modulator apparatus and method
|
JP4173635B2
(ja)
*
|
1997-12-29 |
2008-10-29 |
インターシア セラピューティクス,インコーポレイティド |
膜プラグ保持機構を有する浸透供給装置
|
US7258869B1
(en)
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
US7919109B2
(en)
*
|
1999-02-08 |
2011-04-05 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
WO2002036072A2
(fr)
*
|
2000-11-03 |
2002-05-10 |
Biomedicines, Inc. |
Procede pour une dosimetrie de medicaments a court et a long terme
|
EP1345588A2
(fr)
*
|
2000-12-29 |
2003-09-24 |
Bausch & Lomb Incorporated |
Dispositif d'apport de medicaments en continu
|
WO2002053130A2
(fr)
*
|
2001-01-03 |
2002-07-11 |
Bausch & Lomb Incorporated |
Dispositifs de liberation prolongee de medicaments comprenant des noyaux de medicaments enrobes
|
JP4184082B2
(ja)
*
|
2001-01-03 |
2008-11-19 |
ボシュ・アンド・ロム・インコーポレイテッド |
複数の薬剤を備えた徐放薬剤送達装置
|
US7163688B2
(en)
*
|
2001-06-22 |
2007-01-16 |
Alza Corporation |
Osmotic implant with membrane and membrane retention means
|
CN1585627A
(zh)
|
2001-09-14 |
2005-02-23 |
弗朗西斯J·马丁 |
用于持续释放治疗剂的显微制作的纳米微孔装置
|
NZ532779A
(en)
*
|
2001-11-09 |
2008-04-30 |
Intarcia Therapeutics Inc |
Method for treating diseases with omega interferon
|
JP2005533782A
(ja)
*
|
2002-06-17 |
2005-11-10 |
アルザ コーポレイション |
流体ビヒクル中に分散した浸透剤を含む、押出し力が早く零次になる機関を有する浸透送出システム
|
US20040059228A1
(en)
*
|
2002-09-23 |
2004-03-25 |
Scimed Life Systems, Inc. |
Systems and methods for flushing catheters
|
RU2329823C2
(ru)
*
|
2002-10-29 |
2008-07-27 |
Алза Корпорейшн |
Стабилизированные твердые полипептидные частицы
|
BR0317421A
(pt)
*
|
2002-12-19 |
2005-11-08 |
Alza Corp |
Géis de fase única não-aquosa estável e formulações destes para liberação a partir de um dispositivo implantável
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
CN100548411C
(zh)
*
|
2003-03-31 |
2009-10-14 |
精达制药公司 |
设置有内部压力释放部件的渗透泵
|
WO2004089335A2
(fr)
*
|
2003-03-31 |
2004-10-21 |
Alza Corporation |
Excipients monophasiques non aqueux et formulations les contenant
|
JP2006521898A
(ja)
*
|
2003-03-31 |
2006-09-28 |
アルザ・コーポレーション |
浸透送り出しシステム及び浸透送り出しシステムの始動時間を短縮する方法
|
US20040265351A1
(en)
|
2003-04-10 |
2004-12-30 |
Miller Richard L. |
Methods and compositions for enhancing immune response
|
JP4898431B2
(ja)
*
|
2003-04-29 |
2012-03-14 |
ザ ジェネラル ホスピタル コーポレイション |
複数薬物の持続放出のための方法およびデバイス
|
CA2437639C
(fr)
|
2003-08-11 |
2016-07-05 |
Valera Pharmaceuticals, Inc. |
Dispositifs de distribution de medicaments a long terme dotes de polymeres a base de polyurethane et leur fabrication
|
US20090208540A1
(en)
*
|
2003-08-11 |
2009-08-20 |
Indevus Pharmaceuticals, Inc. |
Implantable device for the delivery of naltrexone and methods of use thereof
|
US7858110B2
(en)
*
|
2003-08-11 |
2010-12-28 |
Endo Pharmaceuticals Solutions, Inc. |
Long term drug delivery devices with polyurethane based polymers and their manufacture
|
AU2004277980A1
(en)
*
|
2003-09-30 |
2005-04-14 |
Alza Corporation |
Osmotically driven active agent delivery device providing an ascending release profile
|
AU2004287402A1
(en)
|
2003-10-31 |
2005-05-19 |
Alza Corporation |
Osmotic pump with self-retaining, fast-start membrane plug
|
MXPA06003065A
(es)
*
|
2003-11-06 |
2006-05-31 |
Alza Corp |
Reductor de velocidad de imbibicion modular para uso con bomba osmotica implantable.
|
US20050175701A1
(en)
*
|
2004-02-10 |
2005-08-11 |
Alza Corporation |
Capillary moderator for osmotic delivery system
|
US20050266087A1
(en)
*
|
2004-05-25 |
2005-12-01 |
Gunjan Junnarkar |
Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
|
US7117870B2
(en)
*
|
2004-07-26 |
2006-10-10 |
Clarity Corporation |
Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
|
US20060045891A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Lovalenti Phillip M |
Density-matched suspension vehicles and pharmaceutical suspensions
|
US20060134176A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
US20060216242A1
(en)
*
|
2005-02-03 |
2006-09-28 |
Rohloff Catherine M |
Suspending vehicles and pharmaceutical suspensions for drug dosage forms
|
WO2006083761A2
(fr)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solutions de solvant/polymere utilisees comme vehicules de suspension
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
JP2008528698A
(ja)
*
|
2005-02-03 |
2008-07-31 |
インターシア セラピューティクス,インコーポレイティド |
埋め込み可能なインターフェロン含有デバイス
|
US7959938B2
(en)
*
|
2005-03-15 |
2011-06-14 |
Intarcia Therapeutics, Inc. |
Polyoxaester suspending vehicles for use with implantable delivery systems
|
US20070015689A1
(en)
|
2005-06-23 |
2007-01-18 |
Alza Corporation |
Complexation of metal ions with polypeptides
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
US7790671B2
(en)
*
|
2005-10-07 |
2010-09-07 |
Codman & Shurtleff, Inc. |
Implantable pump for protein delivery for obesity control by drug infusion into the brain
|
KR101106510B1
(ko)
|
2006-05-30 |
2012-01-20 |
인타르시아 세라퓨틱스 인코포레이티드 |
투피스, 내부채널 삼투압 전달 시스템 유동 조절기
|
DK2049081T3
(da)
|
2006-08-09 |
2013-02-25 |
Intarcia Therapeutics Inc |
Osmotiske leveringssystemer og stempelarrangementer
|
ES2402172T3
(es)
|
2007-04-23 |
2013-04-29 |
Intarcia Therapeutics, Inc |
Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
|
FI7960U1
(fi)
*
|
2007-04-27 |
2008-07-28 |
Bayer Schering Pharma Oy |
Implantoitavan annostelusysteemin membraanikuori
|
EP2240155B1
(fr)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Dispositifs, formulations et méthodes d administration de plusieurs agents bénéfiques
|
EP2344125A1
(fr)
*
|
2008-09-30 |
2011-07-20 |
Endo Pharmaceuticals Solutions Inc. |
Dispositif implantable pour l'administration d'histréline et procédés d'utilisation de celui-ci
|
US9078900B2
(en)
*
|
2008-09-30 |
2015-07-14 |
Braeburn Pharmaceuticals Bvba Sprl |
Implantable device for the delivery of risperidone and methods of use thereof
|
NZ592113A
(en)
*
|
2008-10-15 |
2012-04-27 |
Intarcia Therapeutics Inc |
Highly concentrated drug particles, formulations, suspensions and uses thereof
|
CN107638562B
(zh)
|
2009-09-28 |
2022-12-02 |
精达制药公司 |
基本稳态药物递送的快速建立和/或终止
|
JP2013509422A
(ja)
|
2009-10-30 |
2013-03-14 |
シーエヌエス セラピューティクス,インク. |
改良されたニュールツリン分子
|
US8038650B2
(en)
*
|
2010-02-22 |
2011-10-18 |
Microsert Ltd. |
Slow release liquid drug delivery device
|
US8980253B2
(en)
|
2010-04-26 |
2015-03-17 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
|
CN103096911B
(zh)
|
2010-04-27 |
2018-05-29 |
Atyr 医药公司 |
与异亮氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
AU2011248489B2
(en)
|
2010-04-28 |
2016-10-06 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl tRNA synthetases
|
EP2563383B1
(fr)
|
2010-04-29 |
2017-03-01 |
Atyr Pharma, Inc. |
Découverte innovatrice de compositions thérapeutiques, diagnostiques, et d'anticorps associées aux fragments protéiques des valyle arnt synthétases
|
CN103097523B
(zh)
|
2010-04-29 |
2016-09-28 |
Atyr医药公司 |
与天冬酰胺酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
WO2011150279A2
(fr)
|
2010-05-27 |
2011-12-01 |
Atyr Pharma, Inc. |
Découverte innovante de compositions thérapeutiques, de diagnostic et d'anticorps liées à fragments protéiques de glutaminyl-arnt synthétases
|
CA2797277C
(fr)
|
2010-05-03 |
2021-02-23 |
Atyr Pharma, Inc. |
Decouverte innovante de compositions therapeutiques, de diagnostic et d'anticorps liees a des fragments proteiques d'arginyle-arnt synthetases
|
EP2566496B1
(fr)
|
2010-05-03 |
2018-02-28 |
aTyr Pharma, Inc. |
Découverte innovante de compositions thérapeutiques, diagnostiques et à base d'anticorps liées des fragments protéiques de méthionyl-arnt-synthétases
|
US9034321B2
(en)
|
2010-05-03 |
2015-05-19 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
|
CA2798139C
(fr)
|
2010-05-04 |
2019-09-24 |
Atyr Pharma, Inc. |
Decouverte innovante de compositions therapeutiques, diagnostiques et a base d'anticorps liees a des fragments proteiques de complexe multi-arnt synthetase p38
|
CN103200953B
(zh)
|
2010-05-14 |
2017-02-15 |
Atyr 医药公司 |
与苯丙氨酰‑β‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
CN103096914B
(zh)
|
2010-05-17 |
2015-08-12 |
Atyr医药公司 |
与亮氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
AU2011261486B2
(en)
|
2010-06-01 |
2017-02-23 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-tRNA synthetases
|
EP2593125B1
(fr)
|
2010-07-12 |
2017-11-01 |
aTyr Pharma, Inc. |
DÉCOUVERTE INNOVANTE DE COMPOSITIONS THÉRAPEUTIQUES, DE DIAGNOSTIC ET D'ANTICORPS SE RAPPORTANT À DES FRAGMENTS PROTÉIQUES DE GLYCYL-ARNt SYNTHÉTASES
|
CN103108650A
(zh)
|
2010-08-25 |
2013-05-15 |
Atyr医药公司 |
与酪氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
KR101793771B1
(ko)
*
|
2011-06-15 |
2017-11-03 |
오리엔트 파마 컴퍼니 리미티드 |
다층 캡슐 및 이의 제조 방법
|
EP2861522A1
(fr)
*
|
2012-06-14 |
2015-04-22 |
Ceramatec, Inc |
Appareil et procédé permettant de fournir des liquides bénéfiques à une vitesse régulière
|
JP6584956B2
(ja)
|
2012-12-21 |
2019-10-02 |
アステラス インスティテュート フォー リジェネレイティブ メディシン |
多能性幹細胞から血小板を生産するための方法およびその組成物
|
US20160303242A1
(en)
|
2013-12-09 |
2016-10-20 |
Durect Corporation |
Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
US10925639B2
(en)
|
2015-06-03 |
2021-02-23 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
CA3003747A1
(fr)
|
2015-11-05 |
2017-05-11 |
The General Hospital Corporation |
Administration intrathecale de sequences d'acide nucleique codant abcd1 pour traiter l'adrenomyeloneuropathie
|
BR112018073511A2
(pt)
|
2016-05-16 |
2019-03-26 |
Intarcia Therapeutics, Inc. |
polipeptídeos seletivos do receptor de glucagon e métodos de uso dos mesmos
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
EP3528836A1
(fr)
|
2016-10-20 |
2019-08-28 |
Peptron, Inc. |
Procédés d'administration d'un polypeptide neuroprotecteur au système nerveux central
|
MX2019008006A
(es)
|
2017-01-03 |
2019-08-29 |
Intarcia Therapeutics Inc |
Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco.
|
CN110545838A
(zh)
|
2017-03-08 |
2019-12-06 |
因塔西亚制药公司 |
用于从药物递送装置施用致恶心化合物的设备和方法
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
JP2022504596A
(ja)
|
2018-10-11 |
2022-01-13 |
インターシア セラピューティクス,インコーポレイティド |
ヒトアミリンアナログペプチド及び使用方法
|
CA3167217A1
(fr)
|
2020-01-13 |
2021-07-22 |
Durect Corporation |
Systemes d'administration de medicament a liberation prolongee avec impuretes reduites et procedes associes
|